Security, usability, and biometric authentication scheme for electronic voting using multiple keys

We propose electronic voting authentication scheme, which is a key management mechanism for electronic voting system intended to limit the number of attacks on a polling station and strengthen the security control. The motivation is to diversify security requirements of messages exchanged between polling stations. There are different types of messages exchanged between polling stations and each type of message has different security needs. A security mechanism developed on the basis of a single key is not enough to ensure the diverse security needs of voting network. In electronic voting authentication scheme, every polling station is responsible to support three different types of keys. These are global key, pairwise key, and individual key. The global keys are public keys shared with all polling stations in the voting network. The pairwise key can be used for communication with polling stations. Individual keys will be used for communication with the server. To ensure authentication of local broadcast, electronic voting authentication scheme uses one-way key chains in a well-organized way. The support of source authentication is a visible advantage of this scheme. We examine the authentication of electronic voting authentication scheme on numerous attack models. The measurement demonstrates that electronic voting authentication scheme is very operative in protecting against numerous elegant attacks such as wormhole attack, Sybil attack, and HELLO Flood attack. The proposed system is evaluated and the results demonstrate that the proposed system is practical and secure as compared to the direct recording electronic and manual systems

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection

The potential for ischemic preconditioning to reduce infarct size was first recognized more than 30 years ago. Despite extension of the concept to ischemic postconditioning and remote ischemic conditioning and literally thousands of experimental studies in various species and models which identified a multitude of signaling steps, so far there is only a single and very recent study, which has unequivocally translated cardioprotection to improved clinical outcome as the primary endpoint in patients. Many potential reasons for this disappointing lack of clinical translation of cardioprotection have been proposed, including lack of rigor and reproducibility in preclinical studies, and poor design and conduct of clinical trials. There is, however, universal agreement that robust preclinical data are a mandatory prerequisite to initiate a meaningful clinical trial. In this context, it is disconcerting that the CAESAR consortium (Consortium for preclinicAl assESsment of cARdioprotective therapies) in a highly standardized multi-center approach of preclinical studies identified only ischemic preconditioning, but not nitrite or sildenafil, when given as adjunct to reperfusion, to reduce infarct size. However, ischemic preconditioning—due to its very nature—can only be used in elective interventions, and not in acute myocardial infarction. Therefore, better strategies to identify robust and reproducible strategies of cardioprotection, which can subsequently be tested in clinical trials must be developed. We refer to the recent guidelines for experimental models of myocardial ischemia and infarction, and aim to provide now practical guidelines to ensure rigor and reproducibility in preclinical and clinical studies on cardioprotection. In line with the above guideline, we define rigor as standardized state-of-the-art design, conduct and reporting of a study, which is then a prerequisite for reproducibility, i.e. replication of results by another laboratory when performing exactly the same experiment